A high tumor-specific RFVT3 expression as well as its important role in tumor metabolism was previously described in esophageal squamous carcinoma (ESCC) (Jiang et al., 2014) and glioma (Fu et al., 2016). The gene discussed is SLC52A3; the disease is central nervous system cancer.